Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Oncology (Williston Park, N.Y.)
|
February 28, 2002
Chronic inflammation and cancer
Emily Shacter, Sigmund A Weitzman
Journal of Periodontology
|
March 15, 2018
Letter to the Editors
Paul N Baer, Sigmund A Weitzman
Oncology (Williston Park, N.Y.)
|
June 30, 2011
Chronic inflammation and cancer: the role of the mitochondria
David W Kamp, Emily Shacter, Sigmund A Weitzman
American Journal of Respiratory Cell and Molecular Biology
|
January 24, 2003
The mitochondria-regulated death pathway mediates asbestos-induced alveolar epithelial cell apoptosis
Vijayalakshmi Panduri, Sigmund A Weitzman, Navdeep Chandel, et al.
Molecular and Cellular Biochemistry
|
August 7, 2002
Asbestos-induced alveolar epithelial cell apoptosis: role of mitochondrial dysfunction caused by iron-derived free radicals
David W Kamp, Vij ayalakshmi Panduri, Sigmund A Weitzman, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
February 10, 2004
Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis
Vijayalakshmi Panduri, Sigmund A Weitzman, Navdeep S Chandel, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 17, 2005
P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis
Vijayalakshmi Panduri, Sailesh Surapureddi, Saul Soberanes, et al.
The American Journal of Pathology
|
April 28, 2004
Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4
Scott L Kominsky, Mustafa Vali, Dorian Korz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2009
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate
David A Dorr, Rachel Burdon, Dennis P West, et al.
Archives of Internal Medicine
|
May 30, 2007
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers
Charles L Bennett, Jonathan R Nebeker, Paul R Yarnold, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Oncology (Williston Park, N.Y.)
|
February 28, 2002
Chronic inflammation and cancer
Emily Shacter, Sigmund A Weitzman
Journal of Periodontology
|
March 15, 2018
Letter to the Editors
Paul N Baer, Sigmund A Weitzman
Oncology (Williston Park, N.Y.)
|
June 30, 2011
Chronic inflammation and cancer: the role of the mitochondria
David W Kamp, Emily Shacter, Sigmund A Weitzman
American Journal of Respiratory Cell and Molecular Biology
|
January 24, 2003
The mitochondria-regulated death pathway mediates asbestos-induced alveolar epithelial cell apoptosis
Vijayalakshmi Panduri, Sigmund A Weitzman, Navdeep Chandel, et al.
Molecular and Cellular Biochemistry
|
August 7, 2002
Asbestos-induced alveolar epithelial cell apoptosis: role of mitochondrial dysfunction caused by iron-derived free radicals
David W Kamp, Vij ayalakshmi Panduri, Sigmund A Weitzman, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
February 10, 2004
Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis
Vijayalakshmi Panduri, Sigmund A Weitzman, Navdeep S Chandel, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 17, 2005
P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis
Vijayalakshmi Panduri, Sailesh Surapureddi, Saul Soberanes, et al.
The American Journal of Pathology
|
April 28, 2004
Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4
Scott L Kominsky, Mustafa Vali, Dorian Korz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2009
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate
David A Dorr, Rachel Burdon, Dennis P West, et al.
Archives of Internal Medicine
|
May 30, 2007
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers
Charles L Bennett, Jonathan R Nebeker, Paul R Yarnold, et al.
Page
of 1